EichorEICHOR
Study identifier: NCT06321601 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Active Not Recruiting

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

Condition: Vasculitis  ·  Sponsor: Amgen

PhasePhase 3
Planned participants19
Who can joinAll sexes, 6 Years to 17 Years
Healthy volunteersNo

About this study

The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (34)

Emory UniversityAtlanta, Georgia, United States
Riley Hospital for ChildrenIndianapolis, Indiana, United States
University of Minnesota Masonic Childrens Hospital Discovery ClinicMinneapolis, Minnesota, United States
Cohen Children Medical CenterLake Success, New York, United States
University of North CarolinaChapel Hill, North Carolina, United States
Wake Forest University Health SciencesCharlotte, North Carolina, United States
Akron Childrens HospitalAkron, Ohio, United States
Cleveland Clinic FoundationCleveland, Ohio, United States
University of Pittsburgh Medical Center Childrens Hospital of PittsburghPittsburgh, Pennsylvania, United States
Texas Childrens HospitalHouston, Texas, United States
Universitair Ziekenhuis GentGhent, Belgium
Universitair Ziekenhuis Leuven - GasthuisbergLeuven, Belgium

+ 22 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →